Strides Pharma, Amneal Pharmaceuticals partner to launch Icosapent ethyl capsules

Pallavi Madhiraju- December 2, 2023 0

Strides Pharma Science Limited (“Strides”) has joined forces with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) to introduce Icosapent ethyl acid soft gel capsules to the ... Read More

Strides Pharma receives FDA approval for Icosapent Ethyl Capsules

Pallavi Madhiraju- October 4, 2023 0

Strides Pharma Science Limited (Strides) has achieved a significant milestone by announcing the United States Food & Drug Administration (USFDA) approval of Icosapent Ethyl Capsules ... Read More

Amarin bags Vascepa FDA approval for reducing cardiovascular risk

pharmanewsdaily- December 16, 2019 0

Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA) for a new indication and label expansion ... Read More